A new analysis of 22 clinical trials involving nearly 3,000 colorectal cancer survivors found that structured survivorship programs can improve health-related quality of life. The programs included various support services such as exercise, diet advice, and psychological counseling. Researchers measured quality of life in two areas: physical and mental health. They found that survivors who took part in these programs reported significant improvements in both domains compared to those who did not. The physical health score improved by a moderate amount, and the mental health score also showed a meaningful boost. However, the results should be interpreted with caution. The overall quality of the evidence was rated as low to moderate, and there was a lot of variation among the studies. This means that while the findings are promising, they are not definitive. The analysis did not report any safety concerns or side effects. For colorectal cancer survivors, these findings suggest that survivorship programs may offer valuable support after treatment. But more high-quality research is needed to confirm the best approaches and to understand which survivors benefit most.
Meta-analysis finds survivorship programs improve quality of life in colorectal cancer survivorsSurvivorship Programs Improve Quality of Life in Colorectal Cancer
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This is a systematic review and meta-analysis of 22 randomized controlled trials involving 2,949 colorectal cancer survivors. The review synthesized evidence on the effect of survivorship programs on health-related quality of life (HRQoL).
The authors found a significant improvement in the physical domain of HRQoL, with a standardized mean difference (SMD) of 0.52 (95% CI 0.18 to 0.86, P = 0.002). They also found a significant improvement in the mental domain, with an SMD of 0.40 (95% CI 0.06 to 0.74, P = 0.02). Heterogeneity was high for both outcomes (I² = 88% for physical, I² = 86% for mental).
The authors noted that the overall quality of the findings was from low to moderate. A sensitivity analysis involved reducing heterogeneity after removing one study.
The review did not report on specific program components, comparators, or adverse events. The authors acknowledged the high heterogeneity as a limitation.
The authors suggest the findings provide potential evidence for health providers to support colorectal cancer survivors post-treatment, but the low to moderate quality and high heterogeneity warrant caution.